Home › Companies › Kiniksa Pharmaceuticals International, plc › 2025-2026
Compiled from SEC Form N-PX filings and Kiniksa Pharmaceuticals International, plc’s Form 8-K, filed May 29, 2026 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of May 29, 2026: 10 items on Kiniksa Pharmaceuticals International, plc’s Form 8-K, filed May 29, 2026: 10 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore Kiniksa Pharmaceuticals International, plc in the interactive database Compare manager voting policies
These tallies are Kiniksa Pharmaceuticals International, plc’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 29, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Stephen R. Biggar | 37,474,114 | 11,999,916 | 13,825 | -- | 4,425,771 | 76% | Not verified | — |
| Elect Director: G. Bradley Cole | 48,299,818 | 1,174,991 | 13,046 | -- | 4,425,771 | 98% | Not verified | — |
| Elect Director: Barry D. Quart | 48,061,571 | 1,413,338 | 12,946 | -- | 4,425,771 | 97% | Not verified | — |
| 2. To approve the appointment of PricewaterhouseCoopers LLP ("PwC") as the Company's UK statutory auditors until the close of the Company's next Annual Meeting | 53,857,053 | 48,432 | 8,141 | -- | 0 | 99.9% | Not verified | — |
| 3. To ratify the appointment of PwC as the Company's US independent registered public accounting firm for the fiscal year ending December 31, 2026 | 53,857,126 | 48,355 | 8,145 | -- | 0 | 99.9% | Not verified | — |
| 4. To authorize the Company's board of directors, through its audit committee, to determine PwC's remuneration in its capacity as the Company's UK statutory auditors until the close of its next Annual Meeting of Shareholders | 53,890,585 | 12,498 | 10,543 | -- | 0 | 99.9% | Not verified | — |
| 5. To receive the Company's UK statutory annual account and report for the period ended December 31, 2025 | 53,611,179 | 2,032 | 300,415 | -- | 0 | 99.9% | Not verified | — |
| 6. To approve, on an advisory non-binding basis, the Company's UK Statutory Directors' Annual Remuneration Report for the period ended December 31, 2025 | 48,353,142 | 1,104,811 | 29,902 | -- | 4,425,771 | 98% | Not verified | — |
| 7. To approve the Company's UK Statutory Directors' Remuneration Policy | 48,633,937 | 824,799 | 29,119 | -- | 4,425,771 | 98% | Not verified | — |
| 8. To approve, on an advisory non-binding basis, the compensation of the Company's named executive officers | 48,145,082 | 1,334,278 | 8,495 | -- | 4,425,771 | 97% | Not verified | — |
Source: Kiniksa Pharmaceuticals International, plc, Form 8-K, filed with the SEC on May 29, 2026 — read the filing on EDGAR.
Each item below shows how the 232 asset managers that disclosed a Kiniksa Pharmaceuticals International, plc vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Barry D. Quart
Kiniksa Pharmaceuticals International, plc’s own tally for this item (“Elect Director: Barry D. Quart”): 48,061,571 for, 1,413,338 against, per its Form 8-K filed May 29, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 58 asset managers below reported 11,456,128 for, 321,063 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 6,157,387 | 0 | 0 | 0 | For |
| Vanguard | 3,093,980 | 1 | 0 | 0 | For |
| MFS | 432,902 | 0 | 0 | 0 | For |
| Victory Capital | 382,503 | 0 | 0 | 0 | For |
| Dimensional | 0 | 226,131 | 0 | 0 | Against |
| HUSSMAN INVESTMENT TRUST | 160,000 | 0 | 0 | 0 | For |
| Aberdeen | 146,045 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 97,649 | 0 | 0 | 0 | For |
| BlackRock | 94,825 | 0 | 0 | 0 | For |
| Allspring | 92,155 | 0 | 0 | 0 | For |
| AllianceBernstein | 86,090 | 0 | 0 | 0 | For |
| Voya | 0 | 72,099 | 0 | 0 | Against |
| DWS | 61,175 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 60,310 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 55,893 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 53,513 | 0 | 0 | 0 | For |
| Charles Schwab | 49,008 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 47,115 | 0 | 0 | 0 | For |
| 1290 Funds | 40,372 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 35,271 | 0 | 0 | 0 | For |
| Empower | 30,896 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 30,758 | 0 | 0 | 0 | For |
| Invesco | 27,015 | 0 | 0 | 0 | For |
| RBB Fund Trust | 23,955 | 0 | 0 | 0 | For |
| Jackson National | 14,048 | 8,565 | 0 | 0 | Mixed |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: G. Bradley Cole
Kiniksa Pharmaceuticals International, plc’s own tally for this item (“Elect Director: G. Bradley Cole”): 48,299,818 for, 1,174,991 against, per its Form 8-K filed May 29, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 58 asset managers below reported 11,456,347 for, 320,844 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 6,157,387 | 0 | 0 | 0 | For |
| Vanguard | 3,093,980 | 1 | 0 | 0 | For |
| MFS | 432,902 | 0 | 0 | 0 | For |
| Victory Capital | 382,503 | 0 | 0 | 0 | For |
| Dimensional | 0 | 226,131 | 0 | 0 | Against |
| HUSSMAN INVESTMENT TRUST | 160,000 | 0 | 0 | 0 | For |
| Aberdeen | 146,045 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 97,649 | 0 | 0 | 0 | For |
| BlackRock | 94,825 | 0 | 0 | 0 | For |
| Allspring | 92,155 | 0 | 0 | 0 | For |
| AllianceBernstein | 86,090 | 0 | 0 | 0 | For |
| Voya | 0 | 72,099 | 0 | 0 | Against |
| DWS | 61,175 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 60,310 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 55,893 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 53,513 | 0 | 0 | 0 | For |
| Charles Schwab | 49,008 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 47,115 | 0 | 0 | 0 | For |
| 1290 Funds | 40,372 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 35,271 | 0 | 0 | 0 | For |
| Empower | 30,896 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 30,758 | 0 | 0 | 0 | For |
| Invesco | 27,015 | 0 | 0 | 0 | For |
| RBB Fund Trust | 23,955 | 0 | 0 | 0 | For |
| Jackson National | 14,048 | 8,565 | 0 | 0 | Mixed |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
Combines 3 wordings of this item as funds reported it.
76% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Stephen R. Biggar
Kiniksa Pharmaceuticals International, plc’s own tally for this item (“Elect Director: Stephen R. Biggar”): 37,474,114 for, 11,999,916 against, per its Form 8-K filed May 29, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 76% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 58 asset managers below reported 9,712,176 for, 2,065,014 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 6,113,277 | 44,110 | 0 | 0 | For |
| Vanguard | 3,074,617 | 19,363 | 0 | 0 | For |
| MFS | 0 | 432,902 | 0 | 0 | Against |
| Victory Capital | 0 | 382,503 | 0 | 0 | Against |
| Dimensional | 0 | 226,131 | 0 | 0 | Against |
| HUSSMAN INVESTMENT TRUST | 160,000 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 146,045 | 0 | 0 | Against |
| DRIEHAUS MUTUAL FUNDS | 0 | 97,649 | 0 | 0 | Against |
| BlackRock | 94,825 | 0 | 0 | 0 | For |
| Allspring | 0 | 92,155 | 0 | 0 | Against |
| AllianceBernstein | 0 | 86,090 | 0 | 0 | Against |
| Voya | 0 | 72,099 | 0 | 0 | Against |
| DWS | 0 | 61,175 | 0 | 0 | Against |
| CLEARWATER INVESTMENT TRUST | 0 | 60,310 | 0 | 0 | Against |
| Innovator ETFs Trust | 55,893 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 53,513 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 49,008 | 0 | 0 | Against |
| RBB FUND, INC. | 0 | 47,115 | 0 | 0 | Against |
| 1290 Funds | 0 | 40,372 | 0 | 0 | Against |
| Northern Lights Fund Trust IV | 35,271 | 0 | 0 | 0 | For |
| Empower | 30,896 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 0 | 30,758 | 0 | 0 | Against |
| Invesco | 27,015 | 0 | 0 | 0 | For |
| RBB Fund Trust | 23,955 | 0 | 0 | 0 | For |
| Jackson National | 0 | 22,613 | 0 | 0 | Against |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
99.9% Majority: yes · of votes cast
Description as filed by funds: TO RECEIVE THE COMPANY'S UK STATUTORY ANNUAL ACCOUNTS AND REPORT FOR THE PERIOD ENDED DECEMBER 31, 2025.
Kiniksa Pharmaceuticals International, plc’s own tally for this item (“5. To receive the Company's UK statutory annual account and report for the period ended December 31, 2025”): 53,611,179 for, 2,032 against, per its Form 8-K filed May 29, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 57 asset managers below reported 11,776,271 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 6,157,387 | 0 | 0 | 0 | For |
| Vanguard | 3,093,981 | 0 | 0 | 0 | For |
| MFS | 432,902 | 0 | 0 | 0 | For |
| Victory Capital | 382,503 | 0 | 0 | 0 | For |
| Dimensional | 226,131 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 160,000 | 0 | 0 | 0 | For |
| Aberdeen | 146,045 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 97,649 | 0 | 0 | 0 | For |
| BlackRock | 94,825 | 0 | 0 | 0 | For |
| Allspring | 92,155 | 0 | 0 | 0 | For |
| AllianceBernstein | 86,090 | 0 | 0 | 0 | For |
| Voya | 72,099 | 0 | 0 | 0 | For |
| DWS | 61,175 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 60,310 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 55,893 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 53,513 | 0 | 0 | 0 | For |
| Charles Schwab | 49,008 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 47,115 | 0 | 0 | 0 | For |
| 1290 Funds | 40,372 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 35,271 | 0 | 0 | 0 | For |
| Empower | 30,896 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 30,758 | 0 | 0 | 0 | For |
| Invesco | 27,015 | 0 | 0 | 0 | For |
| RBB Fund Trust | 23,955 | 0 | 0 | 0 | For |
| Jackson National | 22,613 | 0 | 0 | 0 | For |
Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.
Combines 6 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: To approve, on an advisory (non- binding) basis, the compensation of our named executive officers.
Kiniksa Pharmaceuticals International, plc’s own tally for this item (“8. To approve, on an advisory non-binding basis, the compensation of the Company's named executive officers”): 48,145,082 for, 1,334,278 against, per its Form 8-K filed May 29, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 6,157,387 | 0 | 0 | 0 | For |
| Vanguard | 3,093,980 | 1 | 0 | 0 | For |
| MFS | 432,902 | 0 | 0 | 0 | For |
| Victory Capital | 382,503 | 0 | 0 | 0 | For |
| Dimensional | 226,131 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 0 | 160,000 | 0 | 0 | Against |
| Aberdeen | 0 | 146,045 | 0 | 0 | Against |
| DRIEHAUS MUTUAL FUNDS | 97,649 | 0 | 0 | 0 | For |
| BlackRock | 94,825 | 0 | 0 | 0 | For |
| Allspring | 92,155 | 0 | 0 | 0 | For |
| AllianceBernstein | 86,090 | 0 | 0 | 0 | For |
| Voya | 72,099 | 0 | 0 | 0 | For |
| DWS | 61,175 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 60,310 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 55,893 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 53,513 | 0 | 0 | 0 | For |
| Charles Schwab | 49,008 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 47,115 | 0 | 0 | 0 | For |
| 1290 Funds | 40,372 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 35,271 | 0 | 0 | 0 | For |
| Empower | 30,896 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 30,758 | 0 | 0 | 0 | For |
| Invesco | 0 | 27,015 | 0 | 0 | Against |
| RBB Fund Trust | 23,955 | 0 | 0 | 0 | For |
| Jackson National | 22,613 | 0 | 0 | 0 | For |
Fund voting reports, all 59 managers: 11,438,264 for, 343,327 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 6,779,033 | 0 | 0 | 0 | For |
| Rubric Capital Management LP | 3,721,743 | 0 | 0 | 0 | For |
| BAKER BROS. ADVISORS LP | 2,855,926 | 0 | 0 | 0 | For |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 855,214 | 2,013 | 0 | 0 | For |
| DE Shaw | 706,412 | 0 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 659,001 | 19,150 | 0 | 0 | For |
| Janus Henderson | 598,200 | 0 | 0 | 0 | For |
| AllianceBernstein | 577,034 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 553,927 | 0 | 0 | 0 | For |
| RICE HALL JAMES & ASSOCIATES, LLC | 498,114 | 0 | 0 | 0 | For |
| Soleus Capital Management, L.P. | 459,212 | 0 | 0 | 0 | For |
| Victory Capital | 451,220 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 443,346 | 0 | 0 | 0 | For |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 375,501 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 351,411 | 0 | 0 | Against |
| BALYASNY ASSET MANAGEMENT L.P. | 344,355 | 0 | 0 | 0 | For |
| Two Sigma | 331,802 | 0 | 0 | 0 | For |
| Point72 | 311,799 | 0 | 0 | 0 | For |
| BlackRock | 291,912 | 13,340 | 0 | 0 | For |
| ArrowMark Colorado Holdings LLC | 291,210 | 0 | 0 | 0 | For |
| Citadel | 290,639 | 0 | 0 | 0 | For |
| AQR | 264,651 | 0 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 251,562 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 245,431 | 0 | 0 | 0 | For |
| NEW YORK STATE COMMON RETIREMENT FUND | 0 | 209,617 | 0 | 0 | Against |
Institutional-manager reports, all 189 managers: 25,424,373 for, 858,284 against, 4,021 abstained, 500 not voted. Showing the 25 largest; see all in the interactive database.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: To approve, on an advisory (non-binding) basis, the Company's UK Statutory Directors' Annual Remuneration Report for the period ended December 31, 2025.
Kiniksa Pharmaceuticals International, plc’s own tally for this item (“6. To approve, on an advisory non-binding basis, the Company's UK Statutory Directors' Annual Remuneration Report for the period ended December 31, 2025”): 48,353,142 for, 1,104,811 against, per its Form 8-K filed May 29, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 6,157,387 | 0 | 0 | 0 | For |
| Vanguard | 3,093,980 | 1 | 0 | 0 | For |
| MFS | 432,902 | 0 | 0 | 0 | For |
| Victory Capital | 382,503 | 0 | 0 | 0 | For |
| Dimensional | 226,131 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 0 | 0 | 160,000 | 0 | Abstain |
| Aberdeen | 0 | 146,045 | 0 | 0 | Against |
| DRIEHAUS MUTUAL FUNDS | 97,649 | 0 | 0 | 0 | For |
| BlackRock | 94,825 | 0 | 0 | 0 | For |
| Allspring | 92,155 | 0 | 0 | 0 | For |
| AllianceBernstein | 86,090 | 0 | 0 | 0 | For |
| Voya | 72,099 | 0 | 0 | 0 | For |
| DWS | 61,175 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 60,310 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 55,893 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 53,513 | 0 | 0 | 0 | For |
| Charles Schwab | 49,008 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 47,115 | 0 | 0 | 0 | For |
| 1290 Funds | 40,372 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 35,271 | 0 | 0 | 0 | For |
| Empower | 30,896 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 30,758 | 0 | 0 | 0 | For |
| Invesco | 0 | 27,015 | 0 | 0 | Against |
| RBB Fund Trust | 23,955 | 0 | 0 | 0 | For |
| Jackson National | 22,613 | 0 | 0 | 0 | For |
Fund voting reports, all 58 managers: 11,433,864 for, 183,327 against, 160,000 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Rubric Capital Management LP | 3,721,743 | 0 | 0 | 0 | For |
| BAKER BROS. ADVISORS LP | 2,855,926 | 0 | 0 | 0 | For |
| Soleus Capital Management, L.P. | 459,212 | 0 | 0 | 0 | For |
| BlackRock | 291,912 | 13,340 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 180,599 | 0 | 0 | 0 | For |
| CASTLEARK MANAGEMENT LLC | 161,830 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 86,000 | 0 | 0 | 0 | For |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 75,276 | 0 | 0 | 0 | For |
| Northern Trust | 38,844 | 2,800 | 0 | 0 | Mixed |
| Baird | 35,875 | 0 | 0 | 0 | For |
| Focus Partners Wealth | 10,000 | 0 | 0 | 0 | For |
| Savant Capital, LLC | 9,516 | 0 | 0 | 0 | For |
| ENVESTNET ASSET MANAGEMENT INC | 8,072 | 0 | 0 | 0 | For |
| Cynosure Group, LLC | 7,308 | 0 | 0 | 0 | For |
| Vident Advisory, LLC | 7,271 | 0 | 0 | 0 | For |
| WELLS FARGO ADVISORS FINANCIAL NETWORK, LLC | 4,487 | 0 | 0 | 0 | For |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 0 | 0 | 4,021 | 0 | Abstain |
| Bleakley Financial Group, LLC | 3,910 | 0 | 0 | 0 | For |
| WELLS FARGO CLEARING SERVICES, LLC | 3,880 | 0 | 0 | 0 | For |
| Capita Financial Network | 2,931 | 0 | 0 | 0 | For |
| BankChampaign, National Association | 2,824 | 0 | 0 | 0 | For |
| NORDEN GROUP LLC | 1,134 | 0 | 0 | 0 | For |
| MERCER GLOBAL ADVISORS INC /ADV | 1,028 | 0 | 0 | 0 | For |
| CHOREO, LLC | 887 | 0 | 0 | 0 | For |
| ADIRONDACK TRUST CO | 875 | 0 | 0 | 0 | For |
Institutional-manager reports, all 58 managers: 7,979,591 for, 16,140 against, 4,021 abstained. Showing the 25 largest; see all in the interactive database.
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: TO APPROVE THE COMPANY'S UK STATUTORY DIRECTORS' REMUNERATION POLICY.
Kiniksa Pharmaceuticals International, plc’s own tally for this item (“7. To approve the Company's UK Statutory Directors' Remuneration Policy”): 48,633,937 for, 824,799 against, per its Form 8-K filed May 29, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 6,157,387 | 0 | 0 | 0 | For |
| Vanguard | 3,093,981 | 0 | 0 | 0 | For |
| MFS | 432,902 | 0 | 0 | 0 | For |
| Victory Capital | 382,503 | 0 | 0 | 0 | For |
| Dimensional | 226,131 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 0 | 0 | 160,000 | 0 | Abstain |
| Aberdeen | 0 | 146,045 | 0 | 0 | Against |
| DRIEHAUS MUTUAL FUNDS | 97,649 | 0 | 0 | 0 | For |
| BlackRock | 94,825 | 0 | 0 | 0 | For |
| Allspring | 92,155 | 0 | 0 | 0 | For |
| AllianceBernstein | 86,090 | 0 | 0 | 0 | For |
| Voya | 72,099 | 0 | 0 | 0 | For |
| DWS | 61,175 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 60,310 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 55,893 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 53,513 | 0 | 0 | 0 | For |
| Charles Schwab | 49,008 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 47,115 | 0 | 0 | 0 | For |
| 1290 Funds | 40,372 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 35,271 | 0 | 0 | 0 | For |
| Empower | 30,896 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 30,758 | 0 | 0 | 0 | For |
| Invesco | 27,015 | 0 | 0 | 0 | For |
| RBB Fund Trust | 23,955 | 0 | 0 | 0 | For |
| Jackson National | 22,613 | 0 | 0 | 0 | For |
Fund voting reports, all 59 managers: 11,472,868 for, 148,723 against, 160,000 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ESSEX INVESTMENT MANAGEMENT CO LLC | 323,940 | 0 | 0 | 0 | For |
| BlackRock | 291,085 | 13,340 | 0 | 0 | For |
| Vident Advisory, LLC | 7,271 | 0 | 0 | 0 | For |
| Ethic Inc. | 479 | 0 | 0 | 0 | For |
Institutional-manager reports, all 4 managers: 622,775 for, 13,340 against.
Combines 4 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: To authorize the Company's Board of Directors, through its Audit Committee, to determine PwC's remuneration in its capacity as our UK statutory auditors until the close of the 2027 Annual General Meeting of Shareholders.
Kiniksa Pharmaceuticals International, plc’s own tally for this item (“4. To authorize the Company's board of directors, through its audit committee, to determine PwC's remuneration in its capacity as the Company's UK statutory auditors until the close of its next Annual Meeting of Sharehol”): 53,890,585 for, 12,498 against, per its Form 8-K filed May 29, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 59 asset managers below reported 11,781,591 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 6,157,387 | 0 | 0 | 0 | For |
| Vanguard | 3,093,981 | 0 | 0 | 0 | For |
| MFS | 432,902 | 0 | 0 | 0 | For |
| Victory Capital | 382,503 | 0 | 0 | 0 | For |
| Dimensional | 226,131 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 160,000 | 0 | 0 | 0 | For |
| Aberdeen | 146,045 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 97,649 | 0 | 0 | 0 | For |
| BlackRock | 94,825 | 0 | 0 | 0 | For |
| Allspring | 92,155 | 0 | 0 | 0 | For |
| AllianceBernstein | 86,090 | 0 | 0 | 0 | For |
| Voya | 72,099 | 0 | 0 | 0 | For |
| DWS | 61,175 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 60,310 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 55,893 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 53,513 | 0 | 0 | 0 | For |
| Charles Schwab | 49,008 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 47,115 | 0 | 0 | 0 | For |
| 1290 Funds | 40,372 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 35,271 | 0 | 0 | 0 | For |
| Empower | 30,896 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 30,758 | 0 | 0 | 0 | For |
| Invesco | 27,015 | 0 | 0 | 0 | For |
| RBB Fund Trust | 23,955 | 0 | 0 | 0 | For |
| Jackson National | 22,613 | 0 | 0 | 0 | For |
Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: To approve the appointment of PricewaterhouseCoopers LLP ("PwC") as the Company's UK statutory auditors until the close of the 2027 Annual General Meeting of Shareholders.
Kiniksa Pharmaceuticals International, plc’s own tally for this item (“2. To approve the appointment of PricewaterhouseCoopers LLP ("PwC") as the Company's UK statutory auditors until the close of the Company's next Annual Meeting”): 53,857,053 for, 48,432 against, per its Form 8-K filed May 29, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 58 asset managers below reported 11,777,191 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 6,157,387 | 0 | 0 | 0 | For |
| Vanguard | 3,093,981 | 0 | 0 | 0 | For |
| MFS | 432,902 | 0 | 0 | 0 | For |
| Victory Capital | 382,503 | 0 | 0 | 0 | For |
| Dimensional | 226,131 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 160,000 | 0 | 0 | 0 | For |
| Aberdeen | 146,045 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 97,649 | 0 | 0 | 0 | For |
| BlackRock | 94,825 | 0 | 0 | 0 | For |
| Allspring | 92,155 | 0 | 0 | 0 | For |
| AllianceBernstein | 86,090 | 0 | 0 | 0 | For |
| Voya | 72,099 | 0 | 0 | 0 | For |
| DWS | 61,175 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 60,310 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 55,893 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 53,513 | 0 | 0 | 0 | For |
| Charles Schwab | 49,008 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 47,115 | 0 | 0 | 0 | For |
| 1290 Funds | 40,372 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 35,271 | 0 | 0 | 0 | For |
| Empower | 30,896 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 30,758 | 0 | 0 | 0 | For |
| Invesco | 27,015 | 0 | 0 | 0 | For |
| RBB Fund Trust | 23,955 | 0 | 0 | 0 | For |
| Jackson National | 22,613 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Description as filed by funds: To ratify the appointment of PwC as the Company's US independent registered public accounting firm for the fiscal year ending December 31, 2026.
Kiniksa Pharmaceuticals International, plc’s own tally for this item (“3. To ratify the appointment of PwC as the Company's US independent registered public accounting firm for the fiscal year ending December 31, 2026”): 53,857,126 for, 48,355 against, per its Form 8-K filed May 29, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 57 asset managers below reported 11,776,271 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 6,157,387 | 0 | 0 | 0 | For |
| Vanguard | 3,093,981 | 0 | 0 | 0 | For |
| MFS | 432,902 | 0 | 0 | 0 | For |
| Victory Capital | 382,503 | 0 | 0 | 0 | For |
| Dimensional | 226,131 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 160,000 | 0 | 0 | 0 | For |
| Aberdeen | 146,045 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 97,649 | 0 | 0 | 0 | For |
| BlackRock | 94,825 | 0 | 0 | 0 | For |
| Allspring | 92,155 | 0 | 0 | 0 | For |
| AllianceBernstein | 86,090 | 0 | 0 | 0 | For |
| Voya | 72,099 | 0 | 0 | 0 | For |
| DWS | 61,175 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 60,310 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 55,893 | 0 | 0 | 0 | For |
| OPTIMUM FUND TRUST | 53,513 | 0 | 0 | 0 | For |
| Charles Schwab | 49,008 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 47,115 | 0 | 0 | 0 | For |
| 1290 Funds | 40,372 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 35,271 | 0 | 0 | 0 | For |
| Empower | 30,896 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 30,758 | 0 | 0 | 0 | For |
| Invesco | 27,015 | 0 | 0 | 0 | For |
| RBB Fund Trust | 23,955 | 0 | 0 | 0 | For |
| Jackson National | 22,613 | 0 | 0 | 0 | For |
Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported.
| # | Asset manager | Shares voted |
|---|---|---|
| 1 | Fidelity | 6,157,387 |
| 2 | Vanguard | 3,093,981 |
| 3 | MFS | 432,902 |
| 4 | Victory Capital | 382,503 |
| 5 | Dimensional | 226,131 |
| 6 | HUSSMAN INVESTMENT TRUST | 160,000 |
| 7 | Aberdeen | 146,045 |
| 8 | DRIEHAUS MUTUAL FUNDS | 97,649 |
| 9 | BlackRock | 94,825 |
| 10 | Allspring | 92,155 |
| # | Asset manager | Shares voted |
|---|---|---|
| 1 | Fidelity | 6,779,033 |
| 2 | Rubric Capital Management LP | 3,721,743 |
| 3 | BAKER BROS. ADVISORS LP | 2,855,926 |
| 4 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 857,227 |
| 5 | DE Shaw | 706,412 |
| 6 | ACADIAN ASSET MANAGEMENT LLC | 678,151 |
| 7 | Janus Henderson | 598,200 |
| 8 | AllianceBernstein | 577,034 |
| 9 | PICTET ASSET MANAGEMENT SA | 553,927 |
| 10 | RICE HALL JAMES & ASSOCIATES, LLC | 498,114 |
Shown as share counts, not percentages: no shares-outstanding figure has been matched to Kiniksa Pharmaceuticals International, plc for the 2025-2026 season, so there is no denominator to divide by.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At Kiniksa Pharmaceuticals International, plc's shareholder meeting held May 29, 2026, in the 2025-2026 proxy season, 232 asset managers reported how they voted on 10 ballot items in their SEC Form N-PX filings, covering 1,659 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory (non- binding) basis, the compensation of our named executive… — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Kiniksa Pharmaceuticals International, plc's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 29, 2026.
Kiniksa Pharmaceuticals International, plc proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Download data (CSV): ballot items · votes by manager · column guide.